AAAAAA

   
Results: 1-7 |
Results: 7
A CONTROLLED TRIAL OF ISONIAZID IN PERSONS WITH ANERGY AND HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION WHO ARE AT HIGH-RISK FOR TUBERCULOSIS
Authors: GORDIN FM MATTS JP MILLER C BROWN LS HAFNER R JOHN SL KLEIN M VAUGHN A BESCH CL PEREZ G SZABO S ELSADR W
Citation: Fm. Gordin et al., A CONTROLLED TRIAL OF ISONIAZID IN PERSONS WITH ANERGY AND HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION WHO ARE AT HIGH-RISK FOR TUBERCULOSIS, The New England journal of medicine, 337(5), 1997, pp. 315-320
WEEKLY FLUCONAZOLE FOR THE PREVENTION OF MUCOSAL CANDIDIASIS IN WOMENWITH HIV-INFECTION - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Authors: SCHUMAN P CAPPS L PENG G VAZQUEZ J ELSADR W GOLDMAN AI ALSTON B BESCH CL VAUGHN A THOMPSON MA COBB MN KERKERING T SOBEL JD
Citation: P. Schuman et al., WEEKLY FLUCONAZOLE FOR THE PREVENTION OF MUCOSAL CANDIDIASIS IN WOMENWITH HIV-INFECTION - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Annals of internal medicine, 126(9), 1997, pp. 689
THE IMPACT OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION ON DRUG-RESISTANT TUBERCULOSIS
Authors: GORDIN FM NELSON ET MATTS JP COHN DL ERNST J BENATOR D BESCH CL CRANE LR SAMPSON JH BRAGG PS ELSADR W KOYANDE D POLLARD C TELZAK E STANDRIDGE B ZAHNOW K WALDMANN C WALKER J PABLOVICH S KISSINGER P DEISINGER G FLEMING D NEER C MERKERING TM MILLER GB HALES D ROYBAL A SARAVOLATZ L FABER L KUMI J SIVAPALAN V GUITY C TORRES RA DOWLING C ZBIKOWSKI V KRUPA R SULLIVAN R LUSKINHAWK R TAYLOR VM ALHADDADIN D MOAVEN N BROWN LS JOHN SL ELLISON J MUTH K MIATICO MG DEYTON B GROOM C
Citation: Fm. Gordin et al., THE IMPACT OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION ON DRUG-RESISTANT TUBERCULOSIS, American journal of respiratory and critical care medicine, 154(5), 1996, pp. 1478-1483
2-STAGE TUBERCULIN SKIN TESTING IN INDIVIDUALS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: WEBSTER CT GORDIN FM MATTS JP KORVICK JA MILLER C MUTH K BROWN LS BESCH CL KUMI JO SALVESON C BINCSIK A IRVIN K MAIATICO G
Citation: Ct. Webster et al., 2-STAGE TUBERCULIN SKIN TESTING IN INDIVIDUALS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, American journal of respiratory and critical care medicine, 151(3), 1995, pp. 805-808
ISSUES OF RECRUITMENT, RETENTION, AND COMPLIANCE IN COMMUNITY-BASED CLINICAL-TRIALS WITH TRADITIONALLY UNDERSERVED POPULATIONS
Authors: MORSE EV SIMON PM BESCH CL WALKER J
Citation: Ev. Morse et al., ISSUES OF RECRUITMENT, RETENTION, AND COMPLIANCE IN COMMUNITY-BASED CLINICAL-TRIALS WITH TRADITIONALLY UNDERSERVED POPULATIONS, Applied nursing research, 8(1), 1995, pp. 8-14
COMPLIANCE IN CLINICAL-TRIALS
Authors: BESCH CL
Citation: Cl. Besch, COMPLIANCE IN CLINICAL-TRIALS, AIDS, 9(1), 1995, pp. 1-10
PRIMARY PROPHYLAXIS WITH PYRIMETHAMINE FOR TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE - RESULTS OF A RANDOMIZED TRIAL
Authors: JACOBSON MA BESCH CL CHILD C HAFNER R MATTS JP MUTH K WENTWORTH DN NEATON JD ABRAMS D RIMLAND D PEREZ G GRANT IH SARAVOLATZ LD BROWN LS DEYTON L
Citation: Ma. Jacobson et al., PRIMARY PROPHYLAXIS WITH PYRIMETHAMINE FOR TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE - RESULTS OF A RANDOMIZED TRIAL, The Journal of infectious diseases, 169(2), 1994, pp. 384-394
Risultati: 1-7 |